AR

Amir Reichman

Chief Executive Officer

Scinai Immunotherapeutics Ltd.

Jerusalem District


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Scinai Immunotherapeutics Ltd.
Industry
research
Employees
35.0
Seniority
C suite

Technologies

NSOne Maropost Outlook Microsoft Office 365 Hubspot Google Maps Mobile Friendly Squarespace ECommerce Typekit Vimeo Adobe Media Optimizer Google Font API YouTube Cedexis Radar Google Tag Manager Google Dynamic Remarketing DoubleClick Conversion DoubleClick Linkedin Marketing Solutions

Keywords

biondvax biotechnology recombinant proteins clinical trials nasdaq infectious diseases pharmaceutical pharmaceutical manufacturing gmp gxp therapeutics nanobodies nanoabs antibodies cdmo scinai immunotherapeutics biotechnology: biological products (no diagnostic substances) health care biotechnology research biopharmaceutical immunotherapy nanosized antibodies biological products innovative drugs autoimmune diseases cdmo services cgmp manufacturing analytical methods development preclinical studies drug development scalable services process optimization aseptic processing biological drug development quality management system fda compliance ema regulations pipeline development collaborative research max planck institute university medical center disease management patient compliance efficacy studies clinical study design partnering opportunities strategic alliances vhh antibodies il-17 inhibitors drug commercialization therapeutic solutions precision medicine cost-effective services boutique cdmo immunology research clinical logistics in-vivo studies scientific advisory board portfolio expansion early-stage biotech market needs research collaborations therapeutic development health wellness & fitness hospital & health care medical pharmaceuticals

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans